Aquestive Therapeutics, Inc. (AQST) insider trading

By person

15 insiders · 1 transaction

4.0×

Daniel Barber holds only 4.0 times base salary in stock. $2.65M of shares against $659.89K in salary for 2025.

Salary from the company's own proxy. The shares are what Daniel Barber last reported holding, valued at $4.22, the price Common Stock was last bought or sold at on the open market here, on 15 Oct 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Daniel Barber

President and CEO

—

$105.60K (1) scheduled

−$105.60K

627,317

0.4998%

$2.65M

−24.1%

Stephen Wargacki

Chief Science Officer

—

343,552

0.2737%

$1.45M

+31.4%

Peter E. Boyd

Chief People Officer

—

284,024

0.2263%

$1.20M

+19.5%

A Ernest Toth Jr

Chief Financial Officer

—

283,460

0.2258%

$1.20M

+14.2%

Carl N Kraus

Chief Medical Officer

—

282,475

0.2251%

$1.19M

+12.2%

Melina Cioffi

SVP, Regulatory Affairs

—

273,200

0.2177%

$1.15M

+49.9%

Sherry Korczynski

Chief Commercial Officer

—

235,689

0.1878%

$995.55K

+214.3%

Lori J Braender

Corporate Secretary

—

231,042

0.1841%

$975.92K

−26.2%

Cassie Jung

Chief Operating Officer

—

208,833

0.1664%

$882.11K

−11.2%

Douglas K Bratton

10% owner

—

199,841

0.1592%

$844.13K

−16.7%

John Cochran

Director

—

161,715

0.1288%

$683.08K

+62.6%

Thomas A. Zalewski

Chief Legal Officer

—

100,000

0.0797%

$422.40K

—

Matthew W. Davis

Chief Development Officer

—

100,000

0.0797%

$422.40K

—

Matthew J. Greenhawt

Chief Medical Officer

—

75,000

0.0598%

$316.80K

—

Julie Krop

Director

—

0.0000%

$0.00

—

Aquestive Therapeutics, Inc.

What the insiders did Scheduled selling only

By person